Claude Chemla
Corporate Officer/Principal bij ScreenCell SA
Oorsprong van het eerstegraads netwerk van Claude Chemla
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
ScreenCell SA
 ScreenCell SA Miscellaneous Commercial ServicesCommercial Services ScreenCell SA provides access to circulating rare cells. It offers rare cell isolation solutions for medical and research applications. The company was founded by Patrizia Paterlini-Brechot, Ian Jones and Christian Brechot on April 11, 2001 and is headquartered in Sarcelles, France.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Claude Chemla via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Thomas Jefferson University | College/University | Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal | |
BNP Paribas Développement SA
 BNP Paribas Développement SA Investment ManagersFinance BNP Paribas Développement SA operates as private equity firm. The company was founded in 1988 and is headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
Vysis Sarl
 Vysis Sarl Medical DistributorsDistribution Services Part of Applied Genetic Services Ltd., Vysis Sarl is a French company that distributes pharmaceutical products. Vysis was acquired by Applied Genetic Services Ltd. from Abbott Molecular, Inc. on February 08, 2000 for $1.27 million. | Medical Distributors | Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Corporate Officer/Principal | |
| Université de Montpellier | College/University | Doctorate Degree | |
| Sapienza University of Rome | College/University | Corporate Officer/Principal | |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| SYMETIS SA | Biotechnology | Director/Board Member | |
| Université Fédérale Toulouse Midi-Pyrénées | College/University | Doctorate Degree | |
| ESCP Europe Campus Paris | College/University | Graduate Degree | |
| London Business School | College/University | Undergraduate Degree | |
| Institut d'Études Politiques d'Aix-en-Provence | College/University | Graduate Degree | |
| Ecole des Mines de Nancy | College/University | Undergraduate Degree | |
| Warburg Paribas Becker | Corporate Officer/Principal | ||
| Rawhide Mine | Director/Board Member | ||
| Convac Technologies Ltd. | Chairman | ||
| ABC Group of Cos. | Chief Executive Officer | ||
| Terrin Group | Chief Executive Officer | ||
| Array Genomics | Corporate Officer/Principal | ||
Antabio SAS
 Antabio SAS Pharmaceuticals: MajorHealth Technology Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France. | Pharmaceuticals: Major | Director/Board Member | |
| EARTH ALIVE CLEAN TECHNOLOGIES INC. | Biotechnology | Director/Board Member | |
Kreaxi SASU
 Kreaxi SASU Investment ManagersFinance Kreaxi SASU (Kreaxi) is an independent private equity firm born from the merger of Rhône-Alpes Création and Banexi Ventures Partners. The company is headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
AGX- DPNI SAS
 AGX- DPNI SAS Medical DistributorsDistribution Services AGX- DPNI SAS engages in the distribution of pharmaceutical products and equipment. The company was founded on December 7, 2019 and is headquartered in Voisins-le-Bretonneux, France. | Medical Distributors | Chairman | |
| WESTERN EXPLORATION INC. | Precious Metals | Director/Board Member | |
| Sloan-Kettering Institute for Cancer Research | Corporate Officer/Principal |
Statistieken
Internationaal
| Frankrijk | 17 |
| Verenigde Staten | 11 |
| Zwitserland | 3 |
| Italië | 2 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Consumer Services | 13 |
| Finance | 5 |
| Health Technology | 5 |
| Commercial Services | 3 |
| Distribution Services | 3 |
Operationeel
| Corporate Officer/Principal | 13 |
| Director/Board Member | 9 |
| Chairman | 4 |
| Private Equity Investor | 3 |
| Graduate Degree | 3 |
Sterkste connecties
| Insiders | |
|---|---|
| Nicolas Schlumberger | 10 |
| Sophie Pierrin-Lépinard | 9 |
| Yvon E. Cayre | 9 |
| Jacques Bojin | 6 |
| Ian Jones | 5 |
- Beurs
- Insiders
- Claude Chemla
- Bedrijfsconnecties
